Such transformation favours cancer onset and progression via the TNF-α-induced release of cytokines and angiogenic factors as well as anti-apoptotic factors such as (B-cell CLL/lymphoma 2 (BCL-2)) and cyclin D1 and cyclin E in cancer cells [52,98,99]. The gene discussed is TNF; the disease is cancer.